
Geographic Atrophy in Focus: From Syfovre & Izervay Dominance to Oral, Gene & Cell Therapies Revolutionizing GA
GA treatment market heats up: Syfovre & Izervay lead, while oral, gene, cell therapies and AI‑enabled tools enter, with global growth and supply challenges. AUSTIN, TX, UNITED STATES, June 24, 2025 /EINPresswire.com/ -- 1. Disease Mechanism …